Binex Co

Binex Co EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Binex Co (053030.KQ) as of Nov 14, 2026 is -11.27. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -24.36 — a change of -53.72% (higher).

EV/FCF

-11.27

YoY

-53.72%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Binex Co is 2025 -11.27 . EV/FCF (Enterprise Value to Free Cash Flow) of Binex Co was 2024 -24.36 . It decreases by -53.72% higher compared to the previous year.

The Binex Co EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
42.81 KRW
Jan 1, 2019
234.09 KRW
Jan 1, 2020
37.47 KRW
Jan 1, 2021
28.66 KRW
Jan 1, 2022
-25.05 KRW
Jan 1, 2023
-41.04 KRW
Jan 1, 2024
-24.36 KRW
Jan 1, 2025
-11.27 KRW
The Binex Co EV/FCF history
YEAREV/FCFYoY
-11.27-53.72%
-24.36-40.65%
-41.04+63.80%
-25.05-187.42%
28.66-23.52%
37.47-83.99%
234.09+446.85%
42.81-46.98%
80.74-125.49%
-316.79+4,492.27%
-6.90-94.77%
-131.79—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Binex Co Stock analysis

What does Binex Co do? Binex Co Ltd generates revenue through the manufacturing and sale of pharmaceutical products including digestive system agents, circulatory system agents, ulcer agents, antacids, anti-inflammatory agents, analgesics, gastrointestinal tract regulators, antispasmodics, antiemetic drugs, antihistamines, laxatives, antihypertensive and urinary agents, antibacterial and antibiotic agents, cough and cold remedies, anti-diabetic medicines, ophthalmic solutions, vitamins, nutrients, and various ointments and creams. The company also produces bio medicines and raw materials. Binex Co Ltd distributes its products domestically within Busan and to overseas markets, targeting healthcare providers, pharmacies, and hospitals that purchase pharmaceuticals for patient care and treatment. The firm's product portfolio covers a wide range of therapeutic areas, including gastrointestinal health, cardiovascular support, pain management, respiratory care, and chronic disease management. By offering both branded and generic pharmaceutical solutions, Binex Co Ltd serves diverse customer segments across the domestic and international pharmaceutical markets, leveraging its manufacturing capabilities to meet regional healthcare demands. Binex Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Binex Co stock

EV/FCF (Enterprise Value to Free Cash Flow) of Binex Co is -11.27 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Binex Co changed from -24.36 to -11.27, representing a -53.72% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Binex Co since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Binex Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Binex Co

All Key Metrics — Binex Co